NCT00507507 - A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT) | Biotech Hunter

Enrollment

126

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

February 29, 2012

Study Completion Date

August 31, 2012

Conditions

Chronic Hepatitis B

Interventions

DRUG

Tenofovir DF

Tenofovir disoproxil fumarate (tenofovir DF) 300 mg tablet taken orally once daily

DRUG

FTC

Emtricitabine (FTC) 200 mg capsule taken orally once daily

DRUG

Placebo

Placebo to match FTC taken once daily

Trial Locations (45)

107

Tainan City

807

Kaohsiung City

833

Kaoshiung

1150

Grafton

2050

Camperdown

2145

Westmead

3004

Melbourne

3081

Heidelburg

10021

New York

10969

Berlin

11030

Manhasset

11355

San Francisco

13353

Berlin

20251

Hamburg

30623

Hanover

33136

Miami

38138

Germantown

40237

Düsseldorf

44623

Herne

48202

Detroit

55131

Mainz

59037

Lille

60590

Frankfurt

67091

Strasbourg

69120

Heidelberg

69288

Lyon

90048

Los Angeles

92115

San Diego

98111

Seattle

119074

Singapore

529889

Singapore

10029-6574

New York

T2N4N1

Calgary

V5Z1H2

Vancouver

M5G 2C4

Toronto

Unknown

Pokfulam

Shatin

Tai Po

Hamilton

Taipei

85-030

Bydgoszcz

41-500

Chorzów

01-201

Warsaw

NW3 2QG

London

S10 2JF

Sheffield